ALDH1A1 and pancreatic neoplasm: Lip-FLLL32 sensitized pancreatic cancer cells to gemcitabine chemotherapy and X-ray radiotherapy by repressing tumorsphere formulation and reducing ALDH1+ cell population in xenograft tumors, suggesting the reduction of CSCs.